$TELYF

TELYRX HOLDINGS INC.

TelyRx is a healthcare and pharmacy services company based in Clearwater, Florida. Its digital pharmacy platform connects patients across the United States with physicians for access to routine prescriptions. The company also runs pharmacies that deliver medications to patients’ homes, with next-day shipping. Its services are available to doctors, veterinarians, medical practices and other licensed prescribers.

0
1
0

No SEC Form 4 filings for $TELYF in the last 30 days.

See all $TELYF insider activity →
Med

TelyRx: TelyRx Announces Departure of Chief Revenue Officer

TelyRx Holdings Inc. (TSX: TELY, OTCQX: TELYF) announced the departure of its Chief Revenue Officer, Peter Lloyd, who is leaving to pursue other opportunities. The company's interim CEO, Ben Atkins, expressed gratitude for Lloyd's contributions and stated that the leadership team will temporarily handle his responsibilities. TelyRx is a digital healthcare and pharmacy platform operating in 49 U.S. states and territories, offering over 500 common medications.

TelyRx appoints Benjamin Atkins as interim CEO

TelyRx Holdings (TELY) appointed Benjamin Atkins as interim CEO and President, effective November 12, 2026, following Vanessa Slowey's resignation. Atkins, a co-founder and board member, brings industry experience. The board is searching for a permanent replacement. TELYF shares fell 11.43%.

TELYF sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning TELYF (TELYRX HOLDINGS INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent TELYF coverage spans financial news, corporate actions and earnings.

What's driving TELYF

  • TelyRx Holdings Inc. (TSX: TELY, OTCQX: TELYF) announced the departure of its Chief Revenue Officer, Peter Lloyd, who is leaving to pursue other opportunities. The company's interim CEO, Ben Atkins, expressed gratitude for Lloyd's contributions and stated that the leadership team will temporarily handle his responsibilities. TelyRx is a digital healthcare and pharmacy platform operating in 49 U.S. states and territories, offering over 500 common medications.

    finanznachrichten.de · Nov 18, 2026

  • Leadership transition may cause short‑term uncertainty for the stock.

    seekingalpha.com · Nov 12, 2026

  • TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) appointed Benjamin Atkins to its Board of Directors, replacing Andrew Brandt. Atkins brings 25 years of healthcare and real estate experience. The company aims to scale and move towards profitability, according to management.

    stocktitan.net · Nov 6, 2026

  • TelyRx reported Q3 2026 revenue of $23.1M, up from $12.3M in Q3 2025, but net loss from operations widened to $2.7M from $0.9M. Adjusted EBITDA loss narrowed to $1.3M from $0.4M. The company launched a new brand and website, expanded its formulary, and plans to triple capacity in Clearwater, Florida.

    stocktitan.net · Nov 5, 2026

AlphAI scores every news story that mentions TELYF with an AI model for sentiment and relevance, and aggregates insider trades from TELYRX HOLDINGS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TELYF

Score

TelyRx: TelyRx Announces Departure of Chief Revenue Officer

TelyRx Holdings Inc. (TSX: TELY, OTCQX: TELYF) announced the departure of its Chief Revenue Officer, Peter Lloyd, who is leaving to pursue other opportunities. The company's interim CEO, Ben Atkins, expressed gratitude for Lloyd's contributions and stated that the leadership team will temporarily handle his responsibilities. TelyRx is a digital healthcare and pharmacy platform operating in 49 U.S. states and territories, offering over 500 common medications.

TelyRx appoints Benjamin Atkins as interim CEO

TelyRx Holdings (TELY) appointed Benjamin Atkins as interim CEO and President, effective November 12, 2026, following Vanessa Slowey's resignation. Atkins, a co-founder and board member, brings industry experience. The board is searching for a permanent replacement. TELYF shares fell 11.43%.

Related tickers